Senseonics Holdings, Inc.
Senseonics Holdings, Inc. (NYSE American: SENS) is a medical technology company headquartered in Germantown, Maryland and focused on the development and commercialization of long-term implantable continuous glucose monitoring systems for people with diabetes. The company's website is senseonics.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Senseonics Holdings, Inc. does
In the company’s own words
Senseonics Holdings, Inc. (NYSE American: SENS) is a medical technology company headquartered in Germantown, Maryland and focused on the development and commercialization of long-term implantable continuous glucose monitoring systems for people with diabetes. The company's website is senseonics.com.
The company's primary product is the Eversense CGM system, an implantable glucose monitoring platform consisting of three integrated components: a subcutaneous sensor inserted under the skin in the upper arm, a removable and rechargeable smart transmitter worn over the implantation site, and a mobile application for real-time glucose monitoring. The Eversense 365 system, approved by the FDA in September 2024, provides continuous glucose monitoring for up to twelve months, compared to seven to fifteen days for non-implantable CGM competitors. The Eversense E3 system offers six-month monitoring capability. Both products have received CE Mark approval for commercialization in European Economic Area markets.
Senseonics operates in the early commercialization stage of its Eversense brand. In January 2026, the company assumed full commercial responsibility for Eversense in the United States from distribution partner Ascensia Diabetes Care Holdings AG, establishing its own sales force and marketing operations. The company maintains a network of healthcare provider partners and inserters trained to perform sensor placement procedures. In October 2024, Senseonics acquired the sensor insertion network assets of NPG to expand patient access through its Eon Care subsidiary.
The company generates revenue from sales of Eversense sensor packs, smart transmitter packs, and procedure fees associated with sensor insertion and removal. Reimbursement coverage represents a critical success factor, with approximately three hundred million covered lives in the United States through commercial and government payors including UnitedHealthcare and Medicare. The company also operates patient assistance programs to address access barriers.
Senseonics outsources manufacturing of all Eversense components to contract manufacturers across North America and Europe. The company maintains an intellectual property portfolio of approximately five hundred four issued patents and pending applications worldwide, with expiration dates ranging from 2026 to 2049. Future product development initiatives include the Gemini system, combining CGM and flash glucose monitoring functionality, and the Freedom system incorporating Bluetooth technology to eliminate on-body components.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- GERMANTOWN, MD
- Fiscal year end
- December
- CIK
- 1616543
- SIC
- 3823
Financial performance, year by year
Fiscal 2015–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Senseonics Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Senseonics Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Senseonics Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Senseonics Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Senseonics Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”